1. Home
  2. VSTM vs KUKE Comparison

VSTM vs KUKE Comparison

Compare VSTM & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • KUKE
  • Stock Information
  • Founded
  • VSTM 2010
  • KUKE 2002
  • Country
  • VSTM United States
  • KUKE China
  • Employees
  • VSTM N/A
  • KUKE N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • VSTM Health Care
  • KUKE Real Estate
  • Exchange
  • VSTM Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • VSTM 132.0M
  • KUKE 49.8M
  • IPO Year
  • VSTM 2012
  • KUKE 2021
  • Fundamental
  • Price
  • VSTM $3.88
  • KUKE $0.76
  • Analyst Decision
  • VSTM Strong Buy
  • KUKE
  • Analyst Count
  • VSTM 8
  • KUKE 0
  • Target Price
  • VSTM $14.57
  • KUKE N/A
  • AVG Volume (30 Days)
  • VSTM 1.1M
  • KUKE 834.1K
  • Earning Date
  • VSTM 11-06-2024
  • KUKE 11-05-2024
  • Dividend Yield
  • VSTM N/A
  • KUKE N/A
  • EPS Growth
  • VSTM N/A
  • KUKE N/A
  • EPS
  • VSTM N/A
  • KUKE N/A
  • Revenue
  • VSTM $10,000,000.00
  • KUKE $14,784,158.00
  • Revenue This Year
  • VSTM N/A
  • KUKE N/A
  • Revenue Next Year
  • VSTM $125.69
  • KUKE N/A
  • P/E Ratio
  • VSTM N/A
  • KUKE N/A
  • Revenue Growth
  • VSTM N/A
  • KUKE N/A
  • 52 Week Low
  • VSTM $2.10
  • KUKE $0.47
  • 52 Week High
  • VSTM $14.22
  • KUKE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 63.77
  • KUKE 56.06
  • Support Level
  • VSTM $3.11
  • KUKE $0.47
  • Resistance Level
  • VSTM $3.76
  • KUKE $1.00
  • Average True Range (ATR)
  • VSTM 0.33
  • KUKE 0.16
  • MACD
  • VSTM 0.04
  • KUKE 0.03
  • Stochastic Oscillator
  • VSTM 94.26
  • KUKE 84.92

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: